Correlation of annexin A2 expression with epithelial-mesenchymal transition and extracellular matrix degradation in bile duct carcinoma

摘要

Objective: To investigate the correlation of annexin A2 expression with epithelial-mesenchymal transition (EMT) and extracellular matrix (ECM) degradation in bile duct carcinoma. Methods: A total of 60 patients with primary bile duct carcinoma who accepted bile duct carcinoma laparotomy in our hospital between April 2009 and May 2017 were selected. The bile duct carcinoma tissue and adjacent normal tissue were kept during operation and enrolled in bile duct cancer group (n=60) and normal control group (n=60). The protein expression of annexin A2, EMT marker molecules, MMPs subtypes and TIMPs subtypes in two groups of specimens were detected, and Pearson test was used to evaluate the correlation of annexin A2 expression with EMT and ECM degradation in bile duct carcinoma tissue. Results: Annexin A2 expression in bile duct cancer group was higher than that in normal control group; E-cadherin, β-catenin and syndecan-1 protein expression in bile duct cancer group were lower than those in control group whereas P-cadherin and Vimentin protein expression were higher than those in normal control group; MMP-2, MMP-7 and MMP-9 protein expression in bile duct cancer group were higher than those in normal control group whereas TIMP-1 and TIMP-2 protein expression were lower than those in normal control group. Pearson test showed that the annexin A2 expression in bile duct carcinoma was directly correlated with the protein expression of EMT marker molecules, MMPs subtypes and TIMPs subtypes. Conclusion: annexin A2 increases in bile duct carcinoma, and it can regulate EMT and ECM degradation process to affect the disease outcome.